Topic Archives: Stock Advisor

The Motley Fool is pitching its Stock Advisor Canada service lately with a tease that refers to Amazon’s “Project Vesta” … and it’s all about some Toronto-listed stock that apparently is about to beat Amazon at something. “Beating Amazon” is one of those stories that appeals to everyone, of course — we all want to […]

The ad we’ve been seeing recently from the Motley Fool for their Rule Breakers service is all about this “technology breakthrough” inside a “black box” that a Motley Fool analyst named Rex Moore found inside his son’s apartment — and this “little black box under his TV” that his son called the “heart of his […]

Today, we take you back to 2012… The Motley Fool is promoting it’s “$2.2 Trillion War for your Living Room” stocks again, and the ad is almost identical to the version that first started circulating in the Fall of 2012. That’s not all that shocking, of course — once a newsletter publisher finds an ad […]

“An opportunity this good only comes along once twice in a lifetime. “These 3 quick-action interviews with our Foolish investing experts (below) show how to prepare yourself for the $19 trillion revolution that’s swallowing up the Internet. And how to zero in on the 3 next-generation technology stocks that are best positioned to profit. “I’m […]

Another Motley Fool growth stock to sniff out for you today … David Gardner has gotten a reputation as a compelling “rule breaking” growth stock picker over the past few decades, with some huge winners chosen (and held through very tumultuous times) as he built the Motley Fool with his brother Tom. The flagship Motley […]

That’s our pitch today — that the new “themed” technology investments being teased by the Motley Foolians are as good as David Gardner’s push for AOL and Amazon.com back in the days before the Motley Fool published their current Stock Advisor newsletter. The ad letter actually comes in from a different Fool employee, Todd Etter, […]

That headline is a quote from the Motley Fool, in a recent teaser ad for their flagship Stock Advisor newsletter, the one that pits brother/founders Dave and Tom Gardner against each other. They run through their familiar spiel, that Wall Street ignores the little guy, mutual funds managers underperform and get overpaid, and that brokers […]

“The TRUTH About the Obama Stimulus… “When Ronald Reagan signed his $750 billion stimulus plan in 1981, it snapped the U.S. out of a deep recession, ignited a high-tech revolution, and signaled the start of the greatest bull market in history… “Today, Obama’s stimulus plan could offer even more potential for investors. Because this little-understood […]

“How to multiply YOUR wealth with the behind-the-scenes technology Fortune 500 CEOs are quietly riding to record profits… “Experts call it “the new science of winning.” The Economist says it’s “a golden vein.” FedEx, Capital One, Amazon, and even the Boston Red Sox can’t function without it. “Now a team of professional opportunity-seekers has uncovered […]

“ONE AMERICAN BRAND POISED TO POWER INTO THE GLOBAL MAINSTREAM! “Every decade or so, a brand is born in America that goes up like a moon shot and becomes a recognizable symbol all over the world… Brands like Levis… Coca-Cola… Harley-Davidson… Heinz… McDonalds… GE… Budweiser… Disney… Gillette… Pepsi… The Gap… IBM… Wal-Mart… Apple… Nike… Microsoft… […]

The good folks at Motley Fool’s Stock Advisor newsletter have another teaser for us … they think they’ve got a “virtually recession-proof” stock for you to buy … in their words: “On Sale Now… a Virtually Recession-Proof Business Poised for 100% Gains… “An investment story like this doesn’t come along very often… “It’s a business […]

Comments

  • Avatar

    $GILD $GNFTF I've never heard on Nimbus before. Not sure if their's is a viable NASH product or not. Will stick with ...

  • Avatar

    Dr. KSS: What a day! Do you have any thoughts on GILD's purchase of Nimbus Therapeutics for it's NASH drug? Does this si...

  • LongOnLife

    $GILD News - Gilead Sciences Announces Acquisition of Nimbus Therapeutics’ Acetyl-CoA Carboxlyase (ACC) Program for NA...

  • Avatar

    Great read on the race to treat NASH by CSO of Nimbus Therapeutics. Gilead,Genfit, Zafgen,Merck,Intercept mentioned.Enjo...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info